Literature DB >> 12049585

The distribution of mitochondrial activity in relation to optic nerve structure.

Elizabeth A Bristow1, Philip G Griffiths, Richard M Andrews, Margaret A Johnson, Douglas M Turnbull.   

Abstract

BACKGROUND: The observation of a buildup of mitochondria at the level of the lamina cribrosa in the optic nerve head has traditionally been attributed to axoplasmic stasis. However, this region is also the transition zone for myelination, resulting in differing energy requirements.
OBJECTIVE: To investigate the relationship between myelination and mitochondrial activity in optic nerve tissue.
METHODS: Histological, histochemical, and immunocytochemical techniques were used to demonstrate the distribution of myelin, cytochrome-c oxidase activity, and laminar structure in human optic nerve tissue. A study of rabbit optic nerve and retina and unmyelinated human pituitary stalk was also performed. Cytochrome-c oxidase activity in the human optic nerve tissue was measured using microphotometry.
RESULTS: There was a striking inverse relationship between myelination and mitochondrial distribution in all tissue studied. Statistical analysis of microphotometric data showed this distribution to be highly significant.
CONCLUSION: We caution against the previous inference of a process of axoplasmic stasis and suggest that, instead, the distribution of mitochondria reflects the functional requirement of different regions of the ganglion cell axon. CLINICAL RELEVANCE: Optic neuropathy is associated with several inherited disorders of mitochondria. We suggest that a fine balance exists between energy demand and tissue function in the optic nerve, which may explain why optic nerve pathological features are seen in those with mitochondrial disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12049585     DOI: 10.1001/archopht.120.6.791

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  68 in total

Review 1.  A biomechanical paradigm for axonal insult within the optic nerve head in aging and glaucoma.

Authors:  Claude F Burgoyne
Journal:  Exp Eye Res       Date:  2010-09-16       Impact factor: 3.467

2.  Light effects on mitochondrial photosensitizers in relation to retinal degeneration.

Authors:  N N Osborne; T A Kamalden; A S A Majid; S del Olmo-Aguado; A G Manso; D Ji
Journal:  Neurochem Res       Date:  2010-10-07       Impact factor: 3.996

Review 3.  Dominant optic atrophy.

Authors:  Guy Lenaers; Christian Hamel; Cécile Delettre; Patrizia Amati-Bonneau; Vincent Procaccio; Dominique Bonneau; Pascal Reynier; Dan Milea
Journal:  Orphanet J Rare Dis       Date:  2012-07-09       Impact factor: 4.123

Review 4.  Microenvironmental regulation of oligodendrocyte replacement and remyelination in spinal cord injury.

Authors:  Arsalan Alizadeh; Soheila Karimi-Abdolrezaee
Journal:  J Physiol       Date:  2016-03-29       Impact factor: 5.182

Review 5.  The axonal transport of mitochondria.

Authors:  Peter J Hollenbeck; William M Saxton
Journal:  J Cell Sci       Date:  2005-12-01       Impact factor: 5.285

Review 6.  A hypothesis to suggest that light is a risk factor in glaucoma and the mitochondrial optic neuropathies.

Authors:  N N Osborne; G Lascaratos; A J Bron; G Chidlow; J P M Wood
Journal:  Br J Ophthalmol       Date:  2006-02       Impact factor: 4.638

7.  Mitochondrial membrane potential in axons increases with local nerve growth factor or semaphorin signaling.

Authors:  Jessica Verburg; Peter J Hollenbeck
Journal:  J Neurosci       Date:  2008-08-13       Impact factor: 6.167

Review 8.  The neuro-ophthalmology of mitochondrial disease.

Authors:  J Alexander Fraser; Valérie Biousse; Nancy J Newman
Journal:  Surv Ophthalmol       Date:  2010-05-14       Impact factor: 6.048

Review 9.  Review: Mitochondria and disease progression in multiple sclerosis.

Authors:  D Mahad; H Lassmann; D Turnbull
Journal:  Neuropathol Appl Neurobiol       Date:  2008-12       Impact factor: 8.090

10.  Mitochondrial biogenesis in the axons of vertebrate peripheral neurons.

Authors:  Mandana Amiri; Peter J Hollenbeck
Journal:  Dev Neurobiol       Date:  2008-09-15       Impact factor: 3.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.